Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Transgenesis
Therapeutics
Drug Development
High-throughput in vivo drug validation
Patient-optimised Drug Identification and Analytics
Drug Repurposing
Genetics
AI-driven Drug-Disease Associations
Date founded
2016
Funding rounds raised
Total raised
$56K
from 1 investors over 1 rounds
G
Genome Biologics raised $56K on June 1, 2017
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)